Clinical trial
Contribution of Gabaergic and Glutamatergic Mechanisms to Cognitive Dysfunction
NCT00611572 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contribution of Gabaergic and Glutamatergic Mechanisms to Cognitive Dysfunction
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- October 2, 2018
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.